company background image
SWAV logo

Shockwave Medical NasdaqGS:SWAV Stock Report

Last Price

US$262.55

Market Cap

US$9.9b

7D

1.5%

1Y

38.7%

Updated

28 Feb, 2024

Data

Company Financials +

Shockwave Medical, Inc.

NasdaqGS:SWAV Stock Report

Market Cap: US$9.9b

SWAV Stock Overview

Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally.

SWAV fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance2/6
Financial Health5/6
Dividends0/6

Shockwave Medical, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shockwave Medical
Historical stock prices
Current Share PriceUS$262.55
52 Week HighUS$315.95
52 Week LowUS$157.00
Beta0.88
1 Month Change15.23%
3 Month Change50.42%
1 Year Change38.70%
3 Year Change138.29%
5 Year Changen/a
Change since IPO760.82%

Recent News & Updates

Shockwave Medical: Opening Arteries, Delivering Returns

Feb 28

Recent updates

Shockwave Medical: Opening Arteries, Delivering Returns

Feb 28

Shockwave Medical, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Feb 18
Shockwave Medical, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

There's Been No Shortage Of Growth Recently For Shockwave Medical's (NASDAQ:SWAV) Returns On Capital

Feb 06
There's Been No Shortage Of Growth Recently For Shockwave Medical's (NASDAQ:SWAV) Returns On Capital

Calculating The Fair Value Of Shockwave Medical, Inc. (NASDAQ:SWAV)

Jan 24
Calculating The Fair Value Of Shockwave Medical, Inc. (NASDAQ:SWAV)

Some Shareholders Feeling Restless Over Shockwave Medical, Inc.'s (NASDAQ:SWAV) P/E Ratio

Jan 09
Some Shareholders Feeling Restless Over Shockwave Medical, Inc.'s (NASDAQ:SWAV) P/E Ratio

Is Shockwave Medical (NASDAQ:SWAV) A Risky Investment?

Dec 27
Is Shockwave Medical (NASDAQ:SWAV) A Risky Investment?

Do Shockwave Medical's (NASDAQ:SWAV) Earnings Warrant Your Attention?

Dec 13
Do Shockwave Medical's (NASDAQ:SWAV) Earnings Warrant Your Attention?

What Is Shockwave Medical, Inc.'s (NASDAQ:SWAV) Share Price Doing?

Nov 17
What Is Shockwave Medical, Inc.'s (NASDAQ:SWAV) Share Price Doing?

Is Shockwave Medical, Inc. (NASDAQ:SWAV) Trading At A 50% Discount?

Oct 19
Is Shockwave Medical, Inc. (NASDAQ:SWAV) Trading At A 50% Discount?

Shockwave Medical (NASDAQ:SWAV) Is Very Good At Capital Allocation

Oct 06
Shockwave Medical (NASDAQ:SWAV) Is Very Good At Capital Allocation

Shockwave Medical (NASDAQ:SWAV) Has A Rock Solid Balance Sheet

Sep 20
Shockwave Medical (NASDAQ:SWAV) Has A Rock Solid Balance Sheet

Do Shockwave Medical's (NASDAQ:SWAV) Earnings Warrant Your Attention?

Sep 07
Do Shockwave Medical's (NASDAQ:SWAV) Earnings Warrant Your Attention?

When Should You Buy Shockwave Medical, Inc. (NASDAQ:SWAV)?

Jul 10
When Should You Buy Shockwave Medical, Inc. (NASDAQ:SWAV)?

We Think Shockwave Medical (NASDAQ:SWAV) Might Have The DNA Of A Multi-Bagger

Jun 26
We Think Shockwave Medical (NASDAQ:SWAV) Might Have The DNA Of A Multi-Bagger

We Think Shockwave Medical (NASDAQ:SWAV) Can Manage Its Debt With Ease

Jun 13
We Think Shockwave Medical (NASDAQ:SWAV) Can Manage Its Debt With Ease

Is Now The Time To Put Shockwave Medical (NASDAQ:SWAV) On Your Watchlist?

May 29
Is Now The Time To Put Shockwave Medical (NASDAQ:SWAV) On Your Watchlist?

The Trend Of High Returns At Shockwave Medical (NASDAQ:SWAV) Has Us Very Interested

Mar 27
The Trend Of High Returns At Shockwave Medical (NASDAQ:SWAV) Has Us Very Interested

Shockwave Medical's (NASDAQ:SWAV) Earnings Aren't As Good As They Appear

Mar 06
Shockwave Medical's (NASDAQ:SWAV) Earnings Aren't As Good As They Appear

Should You Think About Buying ShockWave Medical, Inc. (NASDAQ:SWAV) Now?

Feb 28
Should You Think About Buying ShockWave Medical, Inc. (NASDAQ:SWAV) Now?

Is ShockWave Medical, Inc. (NASDAQ:SWAV) Trading At A 29% Discount?

Feb 07
Is ShockWave Medical, Inc. (NASDAQ:SWAV) Trading At A 29% Discount?

Shareholder Returns

SWAVUS Medical EquipmentUS Market
7D1.5%0.4%2.1%
1Y38.7%13.4%26.0%

Return vs Industry: SWAV exceeded the US Medical Equipment industry which returned 13.4% over the past year.

Return vs Market: SWAV exceeded the US Market which returned 26% over the past year.

Price Volatility

Is SWAV's price volatile compared to industry and market?
SWAV volatility
SWAV Average Weekly Movement5.7%
Medical Equipment Industry Average Movement8.3%
Market Average Movement6.1%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: SWAV's share price has been volatile over the past 3 months.

Volatility Over Time: SWAV's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20091,001Doug Godshallhttps://shockwavemedical.com

Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system.

Shockwave Medical, Inc. Fundamentals Summary

How do Shockwave Medical's earnings and revenue compare to its market cap?
SWAV fundamental statistics
Market capUS$9.85b
Earnings (TTM)US$147.28m
Revenue (TTM)US$730.23m

66.7x

P/E Ratio

13.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SWAV income statement (TTM)
RevenueUS$730.23m
Cost of RevenueUS$95.39m
Gross ProfitUS$634.84m
Other ExpensesUS$487.56m
EarningsUS$147.28m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 06, 2024

Earnings per share (EPS)3.94
Gross Margin86.94%
Net Profit Margin20.17%
Debt/Equity Ratio109.4%

How did SWAV perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.